NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma
Clinical trial NCT02434081 · COMPLETED
Trial details
- NCT number
- NCT02434081
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-25
- Primary completion
- 2020-02-29
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.